Community Resilience Program for Community Violence
Trial Summary
What is the purpose of this trial?
This trial tests a program where community members meet to discuss and plan ways to improve their neighborhood, focusing on safety and well-being for children and teens. The goal is to make people feel more connected and capable of reducing violence. The study involves neighborhoods in Pittsburgh and includes both youth and adults.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Community Resiliency Collective Efficacy Intervention (CRCEI) for community violence?
Research on similar community resilience programs, like the Communities Advancing Resilience Toolkit (CART), shows that bringing community members together to address local issues can improve community participation, communication, and cooperation. These elements are crucial for building resilience and could be beneficial in addressing community violence.12345
Is the Community Resilience Program for Community Violence safe for participants?
How is the Community Resiliency Collective Efficacy Intervention (CRCEI) treatment different from other treatments for community violence?
The Community Resiliency Collective Efficacy Intervention (CRCEI) is unique because it focuses on building community resilience by engaging local stakeholders in a collaborative process to address community issues, unlike traditional treatments that may focus on individual therapy or law enforcement. This approach emphasizes community participation, resource sharing, and collective problem-solving to enhance the community's ability to adapt and thrive in the face of violence.1381011
Research Team
Elizabeth Miller, MD, PhD
Principal Investigator
University of Pittsburgh
Eligibility Criteria
This trial is for youth (13 years and older) and adults of all genders who live in specific neighborhoods chosen for the study. It's not open to anyone younger than 13 or those living outside these neighborhoods.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Community Resiliency Collective Efficacy Intervention (CRCEI) to engage community members in dialogue on thriving, community leadership, and organizing for social change
Control
Comparison neighborhoods receive health education sessions as a control intervention
Follow-up
Participants are monitored for changes in collective efficacy, neighborhood social norms, and community violence
Treatment Details
Interventions
- Community Resiliency Collective Efficacy Intervention (CRCEI) (Behavioral Intervention)
- Health Education Sessions (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
David Apelian
University of Pittsburgh
Chief Executive Officer since 2019
PhD in Molecular Biology from Rutgers University, MD from the University of Medicine and Dentistry of New Jersey, MBA from Quinnipiac University
Pamela D. Garzone
University of Pittsburgh
Chief Medical Officer
PhD in Clinical Science from the University of Pittsburgh
Centers for Disease Control and Prevention
Collaborator
Dr. Debra Houry
Centers for Disease Control and Prevention
Chief Medical Officer
MD, MPH
Dr. Susan Monarez
Centers for Disease Control and Prevention
Chief Executive Officer
PhD